Bio-Path Holdings (BPTH)
(Delayed Data from NSDQ)
$1.86 USD
-0.05 (-2.62%)
Updated May 29, 2024 04:00 PM ET
After-Market: $1.85 -0.01 (-0.54%) 7:24 PM ET
2-Buy of 5 2
F Value B Growth B Momentum C VGM
Brokerage Reports
Bio-Path Holdings, Inc. [BPTH]
Reports for Purchase
Showing records 101 - 119 ( 119 total )
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G